Search Results
Search for other papers by Christin Krause in
Google Scholar
PubMed
Search for other papers by Martina Grohs in
Google Scholar
PubMed
Search for other papers by Alexander T El Gammal in
Google Scholar
PubMed
Search for other papers by Stefan Wolter in
Google Scholar
PubMed
Search for other papers by Hendrik Lehnert in
Google Scholar
PubMed
Search for other papers by Oliver Mann in
Google Scholar
PubMed
Search for other papers by Jens Mittag in
Google Scholar
PubMed
Search for other papers by Henriette Kirchner in
Google Scholar
PubMed
Introduction Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease in Western countries, affecting for instance more than 10% of all adults in the United States. NAFLD encompasses a wide spectrum of different stages
Search for other papers by Antonia Ertelt in
Google Scholar
PubMed
Search for other papers by Ann-Kristin Barton in
Google Scholar
PubMed
Search for other papers by Robert R Schmitz in
Google Scholar
PubMed
Search for other papers by Heidrun Gehlen in
Google Scholar
PubMed
evidence of sinking of the coffin bone. Figure 3 Lateromedial radiographic image of a physiological positioned hoof with no evidence of rotation or sinking of the coffin bone. Another consequence of HMS is non-alcoholic fatty liver disease. Pathological
Search for other papers by Monika Karczewska-Kupczewska in
Google Scholar
PubMed
Search for other papers by Agnieszka Nikołajuk in
Google Scholar
PubMed
Search for other papers by Magdalena Stefanowicz in
Google Scholar
PubMed
Search for other papers by Natalia Matulewicz in
Google Scholar
PubMed
Search for other papers by Irina Kowalska in
Google Scholar
PubMed
Search for other papers by Marek Strączkowski in
Google Scholar
PubMed
circulating chemerin concentration has been reported in obesity ( 8 , 9 , 10 ) and related comorbidities such as metabolic syndrome ( 11 ), nonalcoholic fatty liver disease (NAFLD) ( 12 ) and type 2 diabetes ( 9 , 13 ). Systemic chemerin concentrations
epiWELL, LLC, Ithaca, New York, USA
Search for other papers by Magnolia Ariza-Nieto in
Google Scholar
PubMed
Search for other papers by Joshua B Alley in
Google Scholar
PubMed
Search for other papers by Sanjay Samy in
Google Scholar
PubMed
Search for other papers by Laura Fitzgerald in
Google Scholar
PubMed
Search for other papers by Francoise Vermeylen in
Google Scholar
PubMed
Search for other papers by Michael L Shuler in
Google Scholar
PubMed
Search for other papers by José O Alemán in
Google Scholar
PubMed
as glucose homeostasis and fatty acid oxidation. Further, it has been well documented that the liver function is influenced by signaling interactions with adipose tissue ( 7 , 8 ). Specifically, DNA methyltransferase 1 (DNMT1) has been described as a
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Pernille H Hellmann in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed
Search for other papers by Katrine R Carlander in
Google Scholar
PubMed
Search for other papers by Katrine B Hansen in
Google Scholar
PubMed
Search for other papers by Julie L Forman in
Google Scholar
PubMed
Search for other papers by Joachim Størling in
Google Scholar
PubMed
Search for other papers by Elizaveta Chabanova in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Holst in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
Sensitivity Check Index, fasting glucose and insulin levels in several clinical studies in individuals with impaired glucose tolerance, obesity, type 2 diabetes and non-alcoholic fatty liver disease, respectively, not caused by glucocorticoids ( 28 , 29 , 36
Search for other papers by Arpna Sharma in
Google Scholar
PubMed
Search for other papers by Vijay Simha Baddela in
Google Scholar
PubMed
Search for other papers by Frank Becker in
Google Scholar
PubMed
Search for other papers by Dirk Dannenberger in
Google Scholar
PubMed
Search for other papers by Torsten Viergutz in
Google Scholar
PubMed
Search for other papers by Jens Vanselow in
Google Scholar
PubMed
often observed in obese women ( 8 ). However, on the contrary, OA (monounsaturated fatty acid) supplementation has shown to protect exocrine pancreatic cells from PA-induced apoptosis thus reducing the rate of pancreatic diseases caused by obesity ( 9
Search for other papers by Barbara J Boucher in
Google Scholar
PubMed
features ( 47 ). The severity of non-alcoholic fatty liver disease, common in diabetes and obesity, relates inversely to vitamin D status, no doubt because both obesity and liver damage will reduce 25-hydroxylation of vitamin D ( 48 , 49 , 50 ). As in any
Search for other papers by Tao Gao in
Google Scholar
PubMed
Search for other papers by Rui Liu in
Google Scholar
PubMed
Search for other papers by Chunli Li in
Google Scholar
PubMed
Search for other papers by Xinglin Chu in
Google Scholar
PubMed
Search for other papers by Qiao Guo in
Google Scholar
PubMed
Search for other papers by Dazhi Ke in
Google Scholar
PubMed
studies have shown that fetuin-B is closely related to obesity and metabolic syndrome and can lead to lipid metabolism disorders. In a clinical case–control study, it was found that people with nonalcoholic fatty liver disease (NAFLD) had an increased
Search for other papers by Xiuzhen Hou in
Google Scholar
PubMed
Search for other papers by Junfeng Zhang in
Google Scholar
PubMed
Search for other papers by Hehong Ma in
Google Scholar
PubMed
Search for other papers by Ming Li in
Google Scholar
PubMed
Search for other papers by Pei Wang in
Google Scholar
PubMed
T Holst JJ Svare JA Clausen TD Nonalcoholic fatty liver disease is prevalent in women with prior gestational diabetes mellitus and independently associated with insulin resistance and waist circumference . Diabetes Care 2017 40 109
Search for other papers by Magnus F G Grøndahl in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed
Search for other papers by Malte P Suppli in
Google Scholar
PubMed
Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Gerrit Van Hall in
Google Scholar
PubMed
Search for other papers by Nicolai J W Albrechtsen in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Department of Clinical Pharmacology, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Copenhagen, Denmark
Copenhagen Center for Translational Research, Copenhagen University Hospital – Bispebjerg and Frederiksberg, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Mikkel B Christensen in
Google Scholar
PubMed
Search for other papers by Asger B Lund in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
of glucagon, hyperglucagonaemia, are observed in several obesity-related diseases including type 2 diabetes and non-alcoholic fatty liver disease where it contributes to an increased risk of hyperglycaemia ( 3 , 4 , 5 , 6 , 7 , 8 , 9 ). The